Industry & Hardware
株式会社リボルナバイオサイエンス
Japan
alive
About
株式会社リボルナバイオサイエンス develops small-molecule therapeutics that directly target RNA using proprietary screening platforms RNA Insight and RNA Domino, focusing on rare genetic and neurological diseases with partnerships and internal pipeline development.
Explore 株式会社リボルナバイオサイエンス's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.